Get the Stockscreener App
118.95
0.84%
0.99
After Hours:
118.37
-0.58
-0.49%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Abbott Laboratories stock is traded at $118.95, with a volume of 3.13M.
It is up +0.84% in the last 24 hours and up +4.14% over the past month.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
See More
Previous Close:
$117.96
Open:
$118.35
24h Volume:
3.13M
Relative Volume:
0.69
Market Cap:
$208.18B
Revenue:
$41.22B
Net Income/Loss:
$5.77B
P/E Ratio:
40.46
EPS:
2.94
Net Cash Flow:
$6.49B
1W Performance:
+2.61%
1M Performance:
+4.14%
6M Performance:
+14.43%
1Y Performance:
+15.81%
1-Day Range:
$118.10
$120.53
1-Week Range:
$115.14
$120.53
52-Week Range:
$99.71
$121.64
Abbott Laboratories Stock (ABT) Company Profile
Name
Abbott Laboratories
Sector
Industry
Phone
(224) 667-6100
Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Compare ABT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-24 | Initiated | Oppenheimer | Outperform |
| Sep-19-24 | Initiated | Piper Sandler | Overweight |
| Jul-30-24 | Downgrade | Edward Jones | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-21-23 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-20-23 | Reiterated | Barclays | Overweight |
| Apr-20-23 | Reiterated | Bernstein | Outperform |
| Apr-20-23 | Reiterated | JP Morgan | Overweight |
| Apr-20-23 | Reiterated | Raymond James | Outperform |
| Apr-20-23 | Reiterated | UBS | Buy |
| Apr-20-23 | Reiterated | Wolfe Research | Underperform |
| Mar-29-23 | Initiated | UBS | Buy |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-27-22 | Reiterated | Credit Suisse | Outperform |
| Jan-27-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | UBS | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-14-21 | Initiated | Redburn | Neutral |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Jan-28-21 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Jun-01-20 | Downgrade | Goldman | Neutral → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-02-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| Feb-07-19 | Reiterated | BofA/Merrill | Buy |
| Jan-02-19 | Downgrade | Citigroup | Neutral → Sell |
| Nov-30-18 | Upgrade | Goldman | Neutral → Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Jan-30-18 | Reiterated | Citigroup | Neutral |
| Jan-25-18 | Reiterated | Stifel | Buy |
| Jan-25-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-02-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Jan-02-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-19-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-19-17 | Reiterated | Stifel | Buy |
View All
Abbott Laboratories Stock (ABT) Latest News
Infant Nutrition Market Detailed Industry Analysis and Key - openPR
Abbott Laboratories (NYSE:ABT) Shares Sold by BNP Paribas - MarketBeat
Glenmede Trust Co. NA Has $172.94 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Transamerica Financial Advisors Inc. Buys Shares of 6,302 Abbott Laboratories (NYSE:ABT) - MarketBeat
Unlocking Intrinsic Value: Analysis of Abbott Laboratories - GuruFocus.com
Judge denies Abbott request for retrial, lower damages in $500M baby formula case - Seeking Alpha
Osteoarthritis Therapeutics Market Size to Reach USD 24.34 Bn by 2034 - GlobeNewswire Inc.
Abbott Laboratories (NYSE:ABT) Holdings Raised by Prospector Partners LLC - MarketBeat
D.A. Davidson & CO. Lowers Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Dai ichi Life Insurance Company Ltd Sells 10,563 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (XSGO:ABT) GF Value Rank : 6 (As of Nov. 26, 2024) - GuruFocus.com
The Manufacturers Life Insurance Company Sells 511,630 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Protein Supplements Market Global Forecast Report and Company Analysis 2025-2033 Featuring Abbott Laboratories, Herbalife, Nestle, Simply Good Foods, WK Kellogg, PepsiCo, and Glanbia - Yahoo Finance
Australia Diabetes Market Forecasts and Company Analysis 2024-2032, Novo Nordisk, Eli Lilly, Roche, Abbott Laboratories, Insuletn, Dexcom, Medtronic, Ypsomed - Yahoo Finance
Brown Brothers Harriman & Co. Sells 37,055 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Dynamic Technology Lab Private Ltd Buys 12,522 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Fisher Asset Management LLC Boosts Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Launches AI-Guided Heart Valve System, Marks First Patient Procedures | ABT Stock News - StockTitan
Abbott Laboratories (NYSE:ABT) Shares Sold by Jennison Associates LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Abbott Laboratories: Investors Should Wait For A Pullback (NYSE:ABT) - Seeking Alpha
Daiwa Securities Group Inc. Buys 23,834 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Capital Investment Counsel LLC Trims Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Summit Trail Advisors LLC Buys 7,804 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 78% of the company - Yahoo Finance
Meridian Wealth Management LLC Takes $2.03 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
20,597 Shares in Abbott Laboratories (NYSE:ABT) Purchased by Nwam LLC - MarketBeat
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
2 Dividend Kings to Buy for a Lifetime of Passive Income - Yahoo Finance
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US - Yahoo Finance
CFS Investment Advisory Services LLC Purchases New Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Raymond James Trust N.A. Sells 5,886 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Raised by Sessa Capital IM L.P. - MarketBeat
Eagle Asset Management Inc. Acquires 77,554 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Primecap Management Co. CA - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Boosts Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Advisors Asset Management Inc. - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
ABT (Abbott Laboratories) Forward Dividend Yield % : 1.90% (As of Nov. 22, 2024) - GuruFocus.com
ABT (Abbott Laboratories) 3-Year EPS without NRI Growth Rat - GuruFocus.com
Abbott Laboratories: A Tale Of Pipeline Productivity and Innovation!Major Drivers - Smartkarma
Abbott Laboratories stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Massachusetts Financial Services Co. MA Has $1.52 Billion Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
German American Bancorp Inc. Raises Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Citizens Financial Group Inc. RI Trims Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
King Luther Capital Management Corp Lowers Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
3 Things to Absolutely Love About Abbott Labs' Q3 Results - AOL
Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch
Is Trending Stock Abbott Laboratories (ABT) a Buy Now? - Yahoo Finance
Portfolio Design Labs LLC Has $2.12 Million Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Acquired by Avior Wealth Management LLC - MarketBeat
Abbott Laboratories Stock (ABT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):